Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial.
Desai J, Alonso G, Kim SH, Cervantes A, Karasic T, Medina L, Shacham-Shmueli E, Cosman R, Falcon A, Gort E, Guren T, Massarelli E, Miller WH Jr, Paz-Ares L, Prenen H, Amatu A, Cremolini C, Kim TW, Moreno V, Ou SI, Passardi A, Sacher A, Santoro A, Stec R, Ulahannan S, Arbour K, Lorusso P, Luo J, Patel MR, Choi Y, Shi Z, Mandlekar S, Lin MT, Royer-Joo S, Chang J, Jun T, Dharia NV, Schutzman JL; GO42144 Investigator and Study Group; Han SW. Desai J, et al. Among authors: kim tw, kim sh. Nat Med. 2024 Jan;30(1):271-278. doi: 10.1038/s41591-023-02696-8. Epub 2023 Dec 5. Nat Med. 2024. PMID: 38052910 Free PMC article. Clinical Trial.
Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors.
Suh KJ, Kim SH, Lee KH, Kim TY, Kim YJ, Han SW, Kang E, Kim EK, Kim K, No JH, Han W, Noh DY, Lee M, Kim HS, Im SA, Kim JH. Suh KJ, et al. Among authors: kim yj, kim sh, kim ty, kim ek, kim hs, kim k, kim jh. Cancer Res Treat. 2017 Oct;49(4):1153-1163. doi: 10.4143/crt.2016.463. Epub 2017 Feb 27. Cancer Res Treat. 2017. PMID: 28253566 Free PMC article.
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast Cancer.
Kim JS, Suh KJ, Lee DW, Woo GU, Kim M, Kim SH, Ryu HS, Lee KH, Kim TY, Han SW, Park SY, Park IA, Kim JH, Im SA. Kim JS, et al. Among authors: kim sh, kim ty, kim m, kim jh. Cancer Res Treat. 2022 Apr;54(2):488-496. doi: 10.4143/crt.2021.394. Epub 2021 Aug 13. Cancer Res Treat. 2022. PMID: 34412194 Free PMC article.
The impact of systematic assessment for adverse events on unscheduled hospital utilization in patients receiving neoadjuvant or adjuvant chemotherapy: A retrospective multicenter study.
Kim JH, Seo S, Kim JH, Koh SJ, Ahn Y, Jung KH, Ahn JH, Kim SB, Kim TW, Hong YS, Kim SY, Kim JE, Kim SW, Lee DH, Lee JC, Choi CM, Yoon S, Jeong JH, Kim HJ, Suh KJ, Kim SH, Kim YJ, Min YJ, Baek JH, Park SR. Kim JH, et al. Among authors: kim sb, kim yj, kim hj, kim tw, kim sw, kim sh, kim sy, kim je. Cancer Med. 2022 Feb;11(3):705-714. doi: 10.1002/cam4.4476. Epub 2021 Dec 9. Cancer Med. 2022. PMID: 34889062 Free PMC article.
Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer.
Park YH, Im SA, Kim SB, Sohn JH, Lee KS, Chae YS, Lee KH, Kim JH, Im YH, Kim JY, Kim TY, Lee KH, Ahn JH, Kim GM, Park IH, Lee SJ, Han HS, Kim SH, Jung KH; Korean Cancer Study Group (KCSG). Park YH, et al. Among authors: kim sb, kim jy, kim ty, kim sh, kim gm, kim jh. Eur J Cancer. 2017 Nov;86:385-393. doi: 10.1016/j.ejca.2017.10.002. Epub 2017 Nov 5. Eur J Cancer. 2017. PMID: 29100193 Clinical Trial.
Fulvestrant plus goserelin versus anastrozole plus goserelin versus goserelin alone for hormone receptor-positive, HER2-negative tamoxifen-pretreated premenopausal women with recurrent or metastatic breast cancer (KCSG BR10-04): a multicentre, open-label, three-arm, randomised phase II trial (FLAG study).
Kim JY, Im SA, Jung KH, Ro J, Sohn J, Kim JH, Park YH, Kim TY, Kim SB, Lee KS, Kim GM, Kim SH, Kim S, Ahn JS, Lee KH, Ahn JH, Park IH, Im YH; breast cancer committee of Korean Cancer Study Group (KCSG). Kim JY, et al. Among authors: kim sb, kim ty, kim sh, kim gm, kim s, kim jh. Eur J Cancer. 2018 Nov;103:127-136. doi: 10.1016/j.ejca.2018.08.004. Epub 2018 Sep 14. Eur J Cancer. 2018. PMID: 30223226 Clinical Trial.
24,407 results
You have reached the last available page of results. Please see the User Guide for more information.